FIH TO CLINICAL ACCELERATION CONCURRENT Tackling Challenges in Cell Therapy for Solid Tumors
Friday, June 2, 2023 09:15 AM - 10:15 AM
Amphitheatre Bleu
FROM FIH TO CLINICAL ACCELERATION
Concurrent
Chair
Bruce Levine, PhD, Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania, USA
Speakers
Christina Coughlin, MD, PhD, CEO, CytoImmune Therapeutics, Inc., USA
Adrian Hayday, PhD, Professor of Immunobiology, King's College London, UK
Khalid Shah, MS, PhD, Professor, Harvard Medical School, USA
While there have been recent approvals for cell therapy to treat hematological malignancies, the treatment of solid tumors is a much greater challenge and numerous approaches are being attempted to address these issues.
Bruce Levine, PhD, Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania, USA
Speakers
Christina Coughlin, MD, PhD, CEO, CytoImmune Therapeutics, Inc., USA
Adrian Hayday, PhD, Professor of Immunobiology, King's College London, UK
Khalid Shah, MS, PhD, Professor, Harvard Medical School, USA
While there have been recent approvals for cell therapy to treat hematological malignancies, the treatment of solid tumors is a much greater challenge and numerous approaches are being attempted to address these issues.
Bruce Levine PhD
Barbara and Edward Netter Professor in Cancer Gene Therapy
University of Pennsylvania
Chair
Barbara and Edward Netter Professor in Cancer Gene Therapy
University of Pennsylvania
Chair
